This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
F-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor (ER)-positive breast cancer compared with F-18 FDG-PET, according to an article published March 4 in Radiology. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PETscans.
Alzheimer’s disease patients with cognitive impairment or dementia who were referred for amyloid PETscans had fewer hospitalizations compared with a matched control group, according to a study published October 9 in JAMA Neurology. Each participant was matched to a control Medicare beneficiary who had not undergone amyloid PET.
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
In a study published April 17 in Clinical Nuclear Medicine , the group at Brigham tested a new TSPO radiotracer they developed for visualizing such activity called F-18 PBR06. The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls. Image courtesy of Clinical Nuclear Medicine.
National Institutes of Health (NIH) has highlighted a study that shows cardiac PETscans can help identify people at risk for Parkinson’s disease and Lewy body dementia. Heart and brain PETscans from a study participant who developed Parkinson’s disease support a “body first” progression.
Dynamic PETscans acquired in half the time of normal scans appear clinically feasible for patients with lung lesions, according to nuclear medicine researchers in Shenzhen, China. The article was published March 5 in EJNMMI Physics. A 60-year-old male patient with clinical suspicion of lung cancer.
PET imaging has revealed brain pathology linked to faster clinical progression of Alzheimer’s disease in patients with ApoE4 gene variants, according to a study published November 6 in JAMA Neurology. A link to the full article can be found here. The study authors included scientists at Eli Lilly and Company.
“To date, F-18 FDG PET findings are currently not taken into account when making a diagnosis for possible, probable, or definite neurosarcoidosis,” noted lead author Jessy Chen, MD, of Charité - Berlin University Medicine, and colleagues. The article was published January 25 in Neurological Research and Practice.
New articles will be published each Monday up until our official anniversary at RSNA 2024. Our article announcing the winners of our annual Minnies award is always highly popular among our members. Mayo Clinic, Jacksonville, FL MOST SIGNIFICANT NEWS EVENT IN RADIOLOGY 1. Hybrid CT/PETscanning 2.
For instance, while the FDA advises that selection of patients for treatment be made using an approved PSMA radiotracer and based on tracer uptake in tumors, they found that most commonly, subjective visual whole-body PSMA-PETscans were performed (33%). In addition, different PET radiotracers are used.
As one of the world’s authorities on prostate cancer treatment, Dr. Zelefsky has made major contributions to the field, shaping clinical practice guidelines and influencing treatment protocols worldwide.
This standard has revolutionized the radiology industry, encompassing many imaging modalities such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, nuclear medicine, PETscans, etc. Exporting and Sharing DICOM files Exporting and sharing DICOM image files are necessary for the clinical workflow.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content